Skip to content

Saturday, October 24, 2026

Author

Ravi Iyer

Covers the business of biotech: funding, hiring, partnerships.

Articles by Ravi Iyer

A gloved researcher loads microsample vials into a chilled rack, glass and steel surfaces catching cold teal laboratory light.

How Orphan Drug Designation Actually Works: Criteria, Incentives and Exclusivity

Ravi Iyer

An engineer adjusting a bioreactor control panel in a facility of glass and brushed steel, teal instrument glow on gloved hands.

Why Biotech Manufacturing Capacity Announcements Are Reshaping U.S. Drug Supply

Ravi Iyer

A researcher in safety glasses reviewing trial safety monitoring charts at a cool-lit laboratory bench.

FDA's Expedited IND Comment Window Nears Close After Gene Therapy Holds

Ravi Iyer

A scientist adjusts a bioreactor control panel in a facility of glass and brushed steel, cool teal-white light, no logos or readouts.

Gilead and Lakefront Complete $1.675 Billion Ouro Medicines Acquisition

Ravi Iyer

A researcher loads labeled sample racks into a benchtop centrifuge, glass and steel surfaces catching cool teal lab light, no logos visible.

FDA Accepts Vertex's Povetacicept BLA in IgA Nephropathy With November Decision

Ravi Iyer

An oncology researcher logs infusion supplies at a clinical trial prep bench in a cool white treatment lab.

Moderna Doses First Patient in Phase 1/2 Trial of mRNA-2808 in Myeloma

Ravi Iyer